يحاول ذهب - حر
INSIDE THE CRAVING FOR HERBAL CIGARETTES
January 12, 2026
|Mint Chennai
Can these smokes become ayurveda’s next big growth driver?
Sometime in late-2021, 40-something Mumbai-based film writer Abhishek found in a routine checkup that his haemoglobin was higher than normal.
His doctor told him it was because of his smoking—Abhishek was getting through 20-40 cigarettes a day—and told him to quit. He didn’t, although he brought it down to six cigarettes a day. “It was enough to bring my haemoglobin back to normal,” he recalled. “But I only quit completely in 2023, when I realized you can really stop smoking if you want.”
Abhishek tried many things in his mission to quit smoking, including herbal cigarettes. But, he said, they were useless. “The main selling point of these herbal cigarettes was they were in a very attractive wooden box,” he told Mint. “Apart from that, they taste like gobar [cowdung].”
He tried other methods as well and failed. Eventually, he kicked the habit a year later with the help of an app.
Another chronic smoker, former corporate lawyer Ashwin, 34, also turned to herbal cigarettes as he tried to kick the habit while struggling with a stressful job in 2015. “I bought this fancy looking wooden box of herbal cigarettes,” he said. “But they tasted so disgusting that I gave them all away to a friend.”
هذه القصة من طبعة January 12, 2026 من Mint Chennai.
اشترك في Magzter GOLD للوصول إلى آلاف القصص المتميزة المنسقة، وأكثر من 9000 مجلة وصحيفة.
هل أنت مشترك بالفعل؟ تسجيل الدخول
المزيد من القصص من Mint Chennai
Mint Chennai
Lenskart wants artificial intelligence to test your eyes
It expects AI-enabled eye testing to become the default foundational layer of eyecare delivery
3 mins
January 13, 2026
Mint Chennai
More companies to take a hit as labour codes debut
Reworked gratuity and leave encashments spell additional expenses for India Inc
2 mins
January 13, 2026
Mint Chennai
HC lifts ban on Zydus cancer biosimilar till patent expiry
In a relief for Zydus Lifesciences, a division bench of the Delhi High Court on Monday allowed the drugmaker to sell and market its biosimilar of the anticancer drug nivolumab in India, citing public interest.
2 mins
January 13, 2026
Mint Chennai
Trump’s investigation of Powell is also a warning to the next Fed chair
The criminal investigation into Federal Reserve Chair Jerome Powell isn’t ultimately about the Fed’s headquarters, or Powell, or even interest rates.
3 mins
January 13, 2026
Mint Chennai
States flag Almont-Kid syrup as tests find contaminants
Syrup found ‘Not of Standard Quality’ with contaminants like toxic ethylene glycol
1 mins
January 13, 2026
Mint Chennai
India at 100: Our choices today will define the next two decades
India's 2047 ambition is not guaranteed but achievable if we address all the potential pitfalls along our development path
4 mins
January 13, 2026
Mint Chennai
Now, inheritance works without probate—but why it still matters
Heirs can now act on a valid will without court cases, easing delays and unlocking assets in undisputed cases
6 mins
January 13, 2026
Mint Chennai
Why VCs have a new deep-tech playbook
where fundraising starts to drag,\" said Chand.
1 min
January 13, 2026
Mint Chennai
TCS, HCLTech deliver Q3 revenue surprise
clearer.
2 mins
January 13, 2026
Mint Chennai
US productivity is rising and it risks warping monetary policy
America's neutral rate ought to be going up but will the Fed listen?
3 mins
January 13, 2026
Listen
Translate
Change font size
